☆ 4.6 Article

Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: Expert clinical opinion

JOURNAL OF CROHNS & COLITIS (2013)

Get Full Text
Add to Collection

Journal

JOURNAL OF CROHNS & COLITIS
Volume 7, Issue 8, Pages 670-677

Publisher

OXFORD UNIV PRESS
DOI: 10.1016/j.crohns.2013.02.014

Keywords

Crohn's disease; Diagnostic tests; Inflammatory bowel disease; Irritable bowel syndrome; Ulcerative colitis

Categories

Gastroenterology & Hepatology

Funding

  1. Abbott
  2. Ardeypharm
  3. Essex/MSD
  4. FALK
  5. Flamentera
  6. Novartis
  7. Tillotts Pharma
  8. UCB
  9. Zeller
  10. Marato
  11. TV3
  12. Shire
  13. Dr Falk Pharma
  14. Ferring
  15. Health Research Board of Ireland
  16. Irish Cancer Society
  17. Science Foundation Ireland
  18. Janssen
  19. Merck
  20. Norgine
  21. Genentech
  22. Mitsubishi
  23. Vifor
  24. Pharmacosmos
  25. Abbott Switzerland
  26. MSD Switzerland
  27. UCB Switzerland
  28. AstraZeneca
  29. MSD
  30. Centocor
  31. IPSEN
  32. Tillotts
  33. MEDA

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.